FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 67 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $325,000 | +34.9% | 11,501 | -52.3% | 0.00% | – |
| Q2 2021 | $241,000 | +3342.9% | 24,101 | +4128.2% | 0.00% | – |
| Q1 2021 | $7,000 | -70.8% | 570 | -74.2% | 0.00% | – |
| Q4 2020 | $24,000 | +300.0% | 2,208 | +232.0% | 0.00% | – |
| Q3 2020 | $6,000 | -68.4% | 665 | -32.6% | 0.00% | – |
| Q2 2020 | $19,000 | +90.0% | 986 | +72.7% | 0.00% | – |
| Q4 2019 | $10,000 | – | 571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |